| Date | Name | Shares | Transaction | Value |
|
Feb 4, 2026
| Charles R. Crisp Director |
63,210
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $112.13 per share |
7,087,737.30
|
|
Feb 4, 2026
| Robert P. Daniels Director |
32,700
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $112.13 per share |
3,666,651.00
|
|
Feb 4, 2026
| Michael P. Donaldson EVP & Chief Legal Officer |
96,513
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $112.13 per share |
10,822,002.69
|
|
Feb 4, 2026
| Janet F. Clark Director |
47,371
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $112.13 per share |
5,311,710.23
|
|
Feb 4, 2026
| Christopher C. Gaut Director |
21,242
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $112.13 per share |
2,381,865.46
|
|
Feb 4, 2026
| Lynn A. Dugle Director |
6,027
| Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $112.13 per share |
675,807.51
|
|
Dec 18, 2025
| John D. Chandler Director |
826
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 28, 2025
| Jeffrey R. Leitzell EVP & COO |
56,969
| Open market or private purchase of non-derivative security Non-derivative transaction at $107.64 per share |
6,132,143.16
|
|
Oct 28, 2025
| Jeffrey R. Leitzell EVP & COO |
56,973
| Open market or private purchase of non-derivative security Non-derivative transaction at $107.97 per share |
6,151,374.81
|
|
Oct 3, 2025
| Ann D. Janssen EVP & Chief Financial Officer |
100,143
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $113.35 per share |
11,351,209.05
|
|
Oct 3, 2025
| Ezra Y. Yacob Chairman & CEO; Director |
247,917
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $113.35 per share |
28,101,391.95
|
|
Oct 1, 2025
| Laura B. Distefano VP & CAO |
24,245
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Oct 1, 2025
| Laura B. Distefano VP & CAO |
18,277
| Grant, award or other acq pursuant to Rule 16b-3(d) |
0.00
|
|
Aug 20, 2025
| Charles R. Crisp Director |
62,455
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $120.02 per share |
7,495,849.10
|
|
Aug 20, 2025
| Charles R. Crisp Director |
62,544
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $119.99 per share |
7,504,654.56
|
|
Apr 4, 2025
| Jeffrey R. Leitzell EVP & COO |
51,769
| Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $128.04 per share |
6,628,502.76
|
|
Apr 4, 2025
| Jeffrey R. Leitzell EVP & COO |
51,732
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $127.89 per share |
6,616,005.48
|
|
Apr 4, 2025
| Jeffrey R. Leitzell EVP & COO |
47,732
| Open market or private sale of non-derivative or derivative security Non-derivative transaction at $127.76 per share |
6,098,240.32
|
|
Apr 4, 2025
| Jeffrey R. Leitzell EVP & COO |
N/A
| Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
0.00
|